Effect of Reflux of Drug During Intravitreal Anti-VEGF Therapies on Foveal Thickness

By Saeed Muhammad Usman   Qureshi Farhan   Batra Ruchika   Clark David  

Seminars in Ophthalmology, Vol. 26, Iss. 2, 2011-03 ,pp. : 61-63

Informa Healthcare

Access to resources Recommend Favorite

Fluctuation Speed as a New Criterion to Evaluate the Efficiency of Intravitreal Anti-VEGF Drugs

By  

Ophthalmologica, Vol. 235, Iss. 4, 2016-04 ,pp. : 242-242

Karger

Access to resources Recommend Favorite

Branch Retinal Vein Occlusion, Macular Ischemia, and Intravitreal Anti-VEGF Therapy

By  

Case Reports in Ophthalmology, Vol. 8, Iss. 1, 2017-04 ,pp. : 271-278

Karger

Access to resources Recommend Favorite

Effect of Dorzolamide/Timolol or Brinzolamide/Timolol Prophylaxis on Intravitreal Anti-VEGF Injection-Induced Intraocular Hypertension

By Kim Gyu-Nam   Han Yong-Seop   Chung In-Young   Seo Seong-Wook   Park Jong-Moon   Yoo Ji-Myong  

Seminars in Ophthalmology, Vol. 28, Iss. 2, 2013-03 ,pp. : 61-67

Informa Healthcare

Access to resources Recommend Favorite

Management of CNV in Angioid Streaks by Intravitreal Use of Specific Anti-VEGF165 Aptamer (Pegaptanib Sodium): Long-Term Results

By ÇÇekiçç Osman   Gööççmez Erhan   Kocabora Mehmet Selim  

Current Eye Research, Vol. 36, Iss. 5, 2011-05 ,pp. : 492-495

Informa Healthcare

Access to resources Recommend Favorite